OOO

OSTEOPORE LIMITED

No trades
See on Supercharts
Market capitalization
‪38.63 M‬AUD
−0.085AUD
‪−4.87 M‬AUD
‪2.22 M‬AUD
‪103.90 M‬
Beta (1Y)
8.01

About OSTEOPORE LIMITED

CEO
Yu Jing Lim
Headquarters
West Perth
Founded
2018
ISIN
AU0000053324
FIGI
BBG00PV5FCD1
Osteopore Ltd. develops and markets bioresorbable polymer implants for neurosurgical, orthopaedic and maxillofacial surgeries. It engages in the production of 3D printed bioresorbable implants that are used in conjunction with surgical procedures to assist with the natural stages of bone healing. Its products include Osteoplug and Osteomesh. The company was founded in November 2003 and is headquartered in West Perth, Australia.
Performance
Revenue to profit conversion
Debt level and coverage
Earnings
Next:
‪0.00‬
Summarizing what the indicators are suggesting.
Oscillators
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Oscillators
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Moving Averages
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Moving Averages
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Trade directly on the supercharts through our supported, fully-verified and user-reviewed brokers.

Frequently Asked Questions

The current price of OSX is 0.400 AUD — it has increased by 17.65% in the past 24 hours.
Depending on the exchange, the stock ticker may vary. For instance, on ASX exchange OSTEOPORE LIMITED stocks are traded under the ticker OSX.
OSX stock is 39.06% volatile and has beta coefficient of 8.01. Check out the list of the most volatile stocks — is OSTEOPORE LIMITED there?
Yes, you can track OSTEOPORE LIMITED financials in yearly and quarterly reports right on TradingView.
OSX stock has risen by 220.00% compared to the previous week, the month change is a 376.19% rise, over the last year OSTEOPORE LIMITED has showed a 88.80% increase.
OSX net income for the last quarter is ‪−1.89 M‬ AUD, while the quarter before that showed ‪−2.98 M‬ AUD of net income which accounts for 36.39% change. Track more OSTEOPORE LIMITED financial stats to get the full picture.
Today OSTEOPORE LIMITED has the market capitalization of ‪38.63 M‬, it has decreased by 45.00% over the last week.
No, OSX doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
Like other stocks, OSX shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade OSTEOPORE LIMITED stock right from TradingView charts — choose your broker and connect to your account.
OSX reached its all-time high on Jul 2, 2020 with the price of 3.950 AUD, and its all-time low was 0.050 AUD and was reached on Mar 14, 2024.
See other stocks reaching their highest and lowest prices.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So OSTEOPORE LIMITED technincal analysis shows the strong buy rating today, and its 1 week rating is buy. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating OSTEOPORE LIMITED stock shows the buy signal. See more of OSTEOPORE LIMITED technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. OSTEOPORE LIMITED EBITDA is ‪−4.34 M‬ AUD, and current EBITDA margin is −200.71%. See more stats in OSTEOPORE LIMITED financial statements.